Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            April 21, 2017
            Published by admin on April 21, 2017
            Categories
            • GBC Blog

            Curetis Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking

            Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking – Product to launch in EMEA at ECCMID Conference April 22-25, 2017 – IAI Panel covers up […]
            Do you like it?0
            Read more
            April 10, 2017
            Published by admin on April 10, 2017
            Categories
            • GBC Blog

            Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe

            Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe – U.S. data set complemented by recent clinical study data from European […]
            Do you like it?0
            Read more
            April 7, 2017
            Published by admin on April 7, 2017
            Categories
            • GBC Blog

            FDA Approves 23andMe’s Genetic Test for Personal Disease Risks

              FDA Approves 23andMe’s Genetic Test for Personal Disease Risks – Agency stresses that product labeling should show test not designed to diagnose, determine treatment or […]
            Do you like it?0
            Read more
            April 6, 2017
            Published by admin on April 6, 2017
            Categories
            • GBC Blog

            Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing

            Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing – Successful completion of GEAR asset and know how transfer from Siemens to Curetis Amsterdam, […]
            Do you like it?0
            Read more
            March 14, 2017
            Published by admin on March 14, 2017
            Categories
            • GBC Blog

            Computational Biologists Predict Antibiotic Resistances Using Biotech

            Computational Biologists Predict Antibiotic Resistances Using Biotech March 10, 2017 06:47 ET | Source: Curetis GmbH Every year, some 25,000 people die in the European Union […]
            Do you like it?0
            Read more
            March 3, 2017
            Published by admin on March 3, 2017
            Categories
            • GBC Blog

            U.S. Department of Veterans Affairs Awards Supply Contract for Epi proColon

            U.S. Department of Veterans Affairs Awards Supply Contract for Epi proColon Berlin (Germany) and Germantown, MD (U.S.A.), March 3, 2017 – Epigenomics AG (Frankfurt Prime Standard: […]
            Do you like it?0
            Read more
            March 2, 2017
            Published by admin on March 2, 2017
            Categories
            • GBC Blog

            Epigenomics Joins Forces to Increase Colorectal Cancer Screening Rates in the United States

            Epigenomics Joins Forces with hundreds of Organizations to Increase Colorectal Cancer Screening Rates in the United States “80% by 2018” is a shared goal to have […]
            Do you like it?0
            Read more
            February 17, 2017
            Published by admin on February 17, 2017
            Categories
            • GBC Blog

            Asterand and MolecularMD Announce Partnership for Biomarker Validation

            Asterand Bioscience and MolecularMD announce a partnership to accelerate targeted therapeutic biomarker validation, optimization, development and commercialization  — PORTLAND, OR and CAMBRIDGE, MA and DETROIT, MI–( […]
            Do you like it?0
            Read more
            February 2, 2017
            Published by admin on February 2, 2017
            Categories
            • GBC Blog

            Epi proColon – A New Look at Colon Cancer Screening (Video)

            Do you like it?0
            Read more
            Prev page
            1234567891011121314151617181920212223242526272829303132333435
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕